As of 2024-12-14, the Intrinsic Value of Catalyst Pharmaceuticals Inc (CPRX) is
31.94 USD. This CPRX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 21.38 USD, the upside of Catalyst Pharmaceuticals Inc is
49.40%.
The range of the Intrinsic Value is 19.19 - 200.25 USD
31.94 USD
Intrinsic Value
CPRX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
19.19 - 200.25 |
31.94 |
49.4% |
| DCF (Growth 10y) |
20.52 - 198.40 |
33.14 |
55.0% |
| DCF (EBITDA 5y) |
17.43 - 21.53 |
19.25 |
-10.0% |
| DCF (EBITDA 10y) |
18.85 - 24.46 |
21.31 |
-0.3% |
| Fair Value |
14.28 - 14.28 |
14.28 |
-33.22% |
| P/E |
16.31 - 29.03 |
21.35 |
-0.1% |
| EV/EBITDA |
16.71 - 26.15 |
21.50 |
0.6% |
| EPV |
11.19 - 14.81 |
13.00 |
-39.2% |
| DDM - Stable |
4.36 - 22.46 |
13.41 |
-37.3% |
| DDM - Multi |
6.25 - 26.35 |
10.25 |
-52.0% |
CPRX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
2,549.99 |
| Beta |
1.23 |
| Outstanding shares (mil) |
119.27 |
| Enterprise Value (mil) |
2,174.30 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.72% |
| Cost of Debt |
4.48% |
| WACC |
6.57% |